Regeneron halts COVID-19 therapeutic trials on sick patients
UPDATED 3:50 PM PT – Friday, October 30, 2020
‘Regeneron’ has paused its trials on the sickest patients following safety concerns.
According to reports on Friday, the pharmaceutical company decided to stop giving its antibody-drug to coronavirus patients on ventilators or those receiving high amounts of oxygen.
However, the company has said it will continue the trial on patients with less severe bouts of the illness.
This comes as another pharmaceutical company, ‘Eli Lilly,’ ended trials on hospitalized patients on Monday after the drug was determined ineffective for severe cases of the coronavirus.